[1]乐张慧,孙建方.单用沙利度胺治疗成人肛周单发朗格汉斯细胞组织细胞增生症1例[J].中国皮肤性病学杂志,2021,(09):1078-1079.[doi:10.13735/j.cjdv.1001-7089.202010094]
点击复制

单用沙利度胺治疗成人肛周单发朗格汉斯细胞组织细胞增生症1例()
分享到:

《中国皮肤性病学杂志》[ISSN:1001-7089/CN:61-1197/R]

卷:
期数:
2021年09期
页码:
1078-1079
栏目:
短篇
出版日期:
2021-09-01

文章信息/Info

文章编号:
1001-7089(2021)09-1078-02
作者:
乐张慧孙建方
中国医学科学院皮肤病医院,江苏 南京210042
分类号:
R 597
DOI:
10.13735/j.cjdv.1001-7089.202010094
文献标志码:
B

参考文献/References:

[1] Grois N,Potschger U,Prosch H,et al.Risk factors for diabetes insipidus in langerhans cell histiocytosis[J].Pediatr Blood Cancer,2006,46(2):228-233.
[2] Jiang W,Li L,He YM,et al.Langerhans cell histiocytosis of the female genital tract:a literature review with additional three case studies in China[J].Arch Gynecol Obstet,2012,285(1):99-103.
[3] Foley S,Panting K,Bell H,et al.Rapid resolution of pri-mary vulval adult Langerhans cell histiocytosis with very potent topical corticosteroids[J].Australas J Dermatol,2011,52(1):e8-e14.
[4] Favara BE,Feller AC,Pauli M,et al.Contemporary classification of histiocytic disorders.The WHO committee on histiocytic/reticulum cell proliferations.Reclassification Working Group of the Histiocyte Society[J].Med Pediatr Oncol,1997,29(3):157-166.
[5] Hoeger PH,Nanduri VR,Harper JI,et al.Long term follow up of topical mustine treatment for cutaneous langerhans cell histiocytosis[J].Arch Dis Child,2000,82(6):483-487.
[6] McClain KL,Kozinetz CA.A phase Ⅱ trial using thalidomide for Langerhans cell histiocytosis[J].Pediatr Blood Cancer,2007,48(1):44-49.
[7] Lindahl LM,Fenger-Gron M,Iversen L.Topical nitrogen mustard therapy in patients with Langerhans cell histiocy-tosis[J].Br J Dermatol,2012,166(3):642-645.
[8] Sander CS,Kaatz M,Elsner P.Successful treatment of cutaneous langerhans cell histiocytosis with thalidomide[J].Dermatology,2004,208(2):149-152.

备注/Memo

备注/Memo:
[通信作者] 孙建方,E-mail:fangmin5758@aliyun.com
更新日期/Last Update: 2021-09-01